Associations of age with serum insulin, proinsulin and the proinsulin-to-insulin ratio: A cross-sectional study

BMC Endocrine Disorders

Volumn 10, Issue , 2010, Pages

  Bryhni, Bente ^a,b   Arnesen, Egil ^b   Jenssen, Trond G ^b,c  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; PROINSULIN;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET BETA CELL; SEX DIFFERENCE;

EID: 78650091381     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-10-21     Document Type: Article

References (47)

1. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, Saydah SH, Williams DE, Geiss LS, Gregg EW. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population. National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2006, 29:1263-1268. 10.2337/dc06-0062, 16732006.
2. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer H-M, Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998, 21:518-524. 10.2337/diacare.21.4.518, 9571335.
3. The DECODE Study Group Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003, 26:61-69. 10.2337/diacare.26.1.61, 12502659, The DECODE Study Group.
4. Bergman RN, Finegood DT, Kahn SE. The evolution of β-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 2002, 32(Suppl 3):35-45. 10.1046/j.1365-2362.32.s3.5.x, 12028373.
5. Scheen AJ. Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion?. Diabetes Metab 2005, 31:5S27-5S34. 10.1016/S1262-3636(05)73649-1, 16415763.
6. Muller DC, Elahi D, Tobin JD, Andres R. Insulin response during the oral glucose tolerance test: The role of age, sex, body fat and the pattern of fat distribution. Aging Clin Exp Res 1996, 8:13-21.
7. Mooy JM, Grootenhuis PA, de Vries H, Bouter LM, Kostense PJ, Heine RJ. Determinants of specific serum insulin concentrations in a general Caucasian population aged 50 to 74 years (the Hoorn Study). Diabet Med 1998, 15:45-52. 10.1002/(SICI)1096-9136(199801)15:1<45::AID-DIA503>3.0.CO;2-M, 9472863.
8. Mykkänen L, Haffner SM, Hales CN, Rönnemaa T, Laakso M. The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects. Diabetes 1997, 46:1990-1995.
9. Singh K, Bønaa KH, Jacobsen BK, Bjørk L, Solberg S. Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study: The Tromsø Study. Am J Epidemiol 2001, 154:236-244. 10.1093/aje/154.3.236, 11479188.
10. Berntsen GKR, Fønnebø V, Tollan A, Søgaard AJ, Magnus JH. Forearm bone mineral density by age in 7,620 men and women. The Tromsø Study, population-based study. Am J Epidemiol 2001, 153:465-473. 10.1093/aje/153.5.465, 11226978.
11. Knutsen SF, Knutsen R. The Tromsø Heart Study: Family approach to intervention on CHD. Feasibility of risk factor reduction in high risk persons-project description. Scand J Soc Med 1989, 17:109-119.
12. Jorde R, Burhol PG, Schulz TB, Waldum HL, Lygren I, Jenssen T, Myhre ES. The effect of a 34-h fast on the meal-induced rises in plasma GIP, serum insulin, and blood glucose in man. Scand J Gastroenterol 1981, 16:109-112.
13. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl 1):S62-S69. American Diabetes Association.
14. Laakso M. How good a marker is insulin level for insulin resistance?. Am J Epidemiol 1993, 137:959-965.
15. Stumvoll M, Fritsche A, Häring H. The OGTT as test for beta cell function?. Eur J Clin Invest 2001, 31:380-381. 10.1046/j.1365-2362.2001.00828.x, 11380588.
16. Porte D, Kahn SE. β-cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes 2001, 50(Suppl 1):S160-S163. 10.2337/diabetes.50.2007.S160, 11272181.
17. Lindberg O, Tilvis RS, Strandberg TE. Does fasting plasma insulin increase by age in the general elderly population?. Aging Clin Exp Res 1997, 9:277-280.
18. Burchfiel CM, Curb JD, Sharp DS, Rodriguez BL, Arakaki R, Chyou P-H, Yano K. Distribution and correlates of insulin in elderly men. The Honolulu Heart Program. Arterioscler Thromb Vasc Biol 1995, 15:2213-2221.
19. Scheen AJ. Pathophysiology of insulin secretion. Ann Endocrinol 2004, 65:29-36.
20. Davies MJ, Rayman G, Gray IP, Day JL, Hales CN. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabet Med 1993, 10:313-320. 10.1111/j.1464-5491.1993.tb00071.x, 8508612.
21. Kahn SE, Halban PA. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 1997, 46:1725-1732. 10.2337/diabetes.46.11.1725, 9356018.
22. Mykkänen L, Haffner SM, Kuusisto J, Pyörälä K, Hales CN, Laakso M. Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia 1995, 38:1176-1182.
23. Røder ME, Schwartz RS, Prigeon RL, Kahn SE. Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels. J Clin Endocrinol Metab 2000, 85:2275-2280.
24. Shimizu M, Kawazu S, Tomono S, Ohno T, Utsugi T, Kato N, Ishii C, Ito Y, Murata K. Age-related alteration of pancreatic β-cell function. Increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese, subjects without glucose intolerance. Diabetes Care 1996, 19:8-11. 10.2337/diacare.19.1.8, 8720525.
25. Fritsche A, Madaus A, Stefan N, Tschritter O, Maerker E, Teigeler A, Häring H, Stumvoll M. Relationships among age, proinsulin conversion, and β-cell function in nondiabetic humans. Diabetes 2002, 51(Suppl 1):S234-S239. 10.2337/diabetes.51.2007.S234, 11815485.
26. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15:539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S, 9686693.
27. Blaak E. Sex differences in the control of glucose homeostatis. Curr Opin Clin Nutr Metab Care 2008, 11:500-504. 10.1097/MCO.0b013e32830467d3, 18542013.
28. Nadal A, Alonso-Magdalena P, Soriano S, Ropero AB, Quesada I. The role of oestrogens in the adaptation of islets to insulin resistance. J Physiol 2009, 587:50031-5037.
29. Kaaja RJ. Metabolic syndrome and the menopause. Menopause Int 2008, 14:21-25. 10.1258/mi.2007.007032, 18380957.
30. Lefèbvre PJ, Scheen AJ. Glucose metabolism and the postprandial state. Eur J Clin Invest 1999, 29(Suppl 2):1-6.
31. Nordestgaard BG, Benn M, Schnohr P, Tybjærg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007, 298:299-308. 10.1001/jama.298.3.299, 17635890.
32. Frayn KN. Insulin resistance, impaired postprandial lipid metabolism and abdominal obesity: a deadly triad. Med Princ Pract 2002, 11(Suppl 2):31-40. 10.1159/000066414, 12444308.
33. Adiels M, Westerbacka J, Soro-Paavonen A, Häkkinen AM, Vehkavaara S, Caslake MJ, Packard C, Olofsson SO, Yki-Järvinen H, Taskinen MR, Borén J. Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 2007, 50:2356-2365. 10.1007/s00125-007-0790-1, 17849096.
34. Thamer C, Tschritter O, Haap M, Shirkavand F, Machann J, Fritsche A, Schick F, Häring H, Stumvoll M. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm Metab Res 2005, 37:246-251. 10.1055/s-2005-861411, 15952086.
35. Brogna A, Loreno M, Catalano F, Bucceri AM, Malaguarnera M, Muratore LA, Travali S. Radioisotopic assessment of gastric emptying of solids in elderly subjects. Aging Clin Exp Res 2006, 18:493-496.
36. Henriksen JH, Tronier B, Bülow JB. Kinetics of circulating endogenous insulin, C-peptide, and proinsulin in fasting nondiabetic man. Metabolism 1987, 36:463-468. 10.1016/0026-0495(87)90044-8, 3553849.
37. Alvestrand A. Carbohydrate and insulin metabolism in renal failure. Kidney Int 1997, 52(Suppl 62):S48-S52.
38. Levey AS, Coresh J, Greene T, Stevens LA, Zhang Y, Hendriksen S, Kusek JW, Van Lente F. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145:247-254.
39. Steiner DF. New aspects of proinsulin physiology and pathophysiology. J Pediatr Endocrinol Metab 2000, 13:229-239.
40. Facchini FS, Hollenbeck CB, Jeppesen J, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992, 339:1128-1130. 10.1016/0140-6736(92)90730-Q, 1349365.
41. Östgren CJ, Lindblad U, Ranstam J, Melander A, Råstam L. Associations between smoking and β-cell function in a non-hypertensive and non-diabetic population. Diabet Med 2000, 17:445-450.
42. Yoshikawa H, Hellström-Lindahl E, Grill V. Evidence for functional nicotinic receptors on pancreatic beta cells. Metabolism 2005, 54:247-254. 10.1016/j.metabol.2004.08.020, 15690320.
43. Palatini P, Julius S. Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens 2004, 26:637-644. 10.1081/CEH-200031959, 15702618.
44. Facchini FS, Stoohs RA, Reaven GM. Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens 1996, 10:1013-1017.
45. Festa A, D'Agostino R, Hales CN, Mykkänen L, Haffner SM. Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care 2000, 23:624-628. 10.2337/diacare.23.5.624, 10834420.
46. Bloem CJ, Chang AM. Short-term exercise improves β-cell function and insulin resistance in older people with impaired glucose tolerance. J Clin Endocrinol Metab 2008, 93:387-392. 10.1210/jc.2007-1734, 2243226, 18000089.
47. Utzschneider KM, Carr DB, Barsness SM, Kahn SE, Schwartz RS. Diet-induced weight loss is associated with an improvement in β-cell function in older men. J Clin Endocrinol Metab 2004, 89:2704-2710. 10.1210/jc.2003-031827, 15181045.